BeOne Medicines (ONC) Change in Acquisitions & Divestments (2015 - 2025)

BeOne Medicines (ONC) has reported Change in Acquisitions & Divestments for 11 consecutive years, with $1.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $3.4 million (up 29.79% YoY), while the FY2025 annual figure was $3.4 million, up 29.79% from the prior year.
• Change in Acquisitions & Divestments slipped to $1.6 million in Q4 2025 per ONC's latest filing, from $1.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $1.1 billion in Q1 2021 and bottomed at -$10000.0 in Q4 2021.
• Historically, Change in Acquisitions & Divestments has averaged $333.4 million across 5 years, with a median of $211.2 million in 2022.
• Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments slumped 100.0% — and 2022, when it jumped 2112300.0%.
• BeOne Medicines' Change in Acquisitions & Divestments stood at -$10000.0 in 2021, then surged by 2112300.0% to $211.2 million in 2022, then tumbled by 49.95% to $105.7 million in 2023, then sank by 97.49% to $2.7 million in 2024, then tumbled by 38.0% to $1.6 million in 2025.
• Business Quant data shows ONC's Change in Acquisitions & Divestments at $1.6 million in Q4 2025, $1.8 million in Q1 2025, and $2.7 million in Q1 2024.